Antegrade crystalloid cardioplegia vs antegrade/retrograde cold and tepid blood cardioplegia in CABG

被引:24
作者
Elwatidy, AMF [1 ]
Fadalah, MA [1 ]
Bukhari, EA [1 ]
Aljubair, KA [1 ]
Syed, A [1 ]
Ashmeg, AK [1 ]
Alfagih, MR [1 ]
机构
[1] Prince Sultan Cardiac Ctr, Riyadh, Saudi Arabia
关键词
D O I
10.1016/S0003-4975(99)00359-8
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background. This study evaluated the myocardial protective strategies in isolated coronary bypass surgeries. Methods. One hundred and twenty-eight patients were prospectively randomized to 3 techniques of myocardial protection; group I (n = 47) antegrade/retrograde tepid blood cardioplegia, group II (n = 40) antegrade/retrograde cold blood cardioplegia with topical cooling, group III (n = 41) antegrade crystalloid cardioplegia with topical cooling. Results. The incidence of spontaneous defibrillation was significantly higher in group I (p < 0.001) while the incidence of low cardiac output was not different between the 3 groups. The incidence of ventricular arrhythmia was higher in group III (p < 0.016 group III vs I). There was no significant statistical difference in hemodynamic recovery between the 3 groups. CK-MB levels were significantly lower in group I versus the other 2 groups, (p = 0.0013, 0.04). Acid release and oxygen extraction were higher in group II than in group I (p = 0.06) during cardioplegia and reperfusion. Lactate release was less in group I at the release of aortic cross-clamp, and reperfusion. There was no significant difference between the 3 groups in ICU stay, ventilation time, or hospital complications. Conclusions. Tepid blood cardioplegia showed superiority in metabolic and functional recovery, whereas crystalloid cardioplegia had the highest incidence of postoperative arrhythmias. There was no significant statistical difference between the 3 groups in hospital mortality and morbidity. (C) 1999 by The Society of Thoracic Surgeons.
引用
收藏
页码:447 / 453
页数:7
相关论文
共 20 条
[1]
CLINICAL-EVALUATION OF HYPOTHERMIC VENTRICULAR-FIBRILLATION, MULTIDOSE BLOOD CARDIOPLEGIA, AND SINGLE-DOSE BRETSCHNEIDER CARDIOPLEGIA IN CORONARY SURGERY [J].
BEYERSDORF, F ;
KRAUSE, E ;
SARAI, K ;
SIEBER, B ;
DEUTSCHLANDER, N ;
ZIMMER, G ;
MAINKA, L ;
PROBST, S ;
ZEGELMAN, M ;
SCHNEIDER, W ;
SATTER, P .
THORACIC AND CARDIOVASCULAR SURGEON, 1990, 38 (01) :20-29
[2]
UPDATE ON CURRENT TECHNIQUES OF MYOCARDIAL PROTECTION [J].
BUCKBERG, GD .
ANNALS OF THORACIC SURGERY, 1995, 60 (03) :805-814
[3]
CHEN Y-F, 1989, Kaohsiung Journal of Medical Sciences, V5, P548
[4]
CRAVER JM, 1978, J THORAC CARDIOV SUR, V76, P24
[5]
ASPECTS OF MYOCARDIAL PROTECTION [J].
EBERT, PA .
ANNALS OF THORACIC SURGERY, 1978, 26 (06) :495-496
[6]
FOLLETTE DM, 1978, J THORAC CARDIOV SUR, V76, P604
[7]
TEPID ANTEGRADE AND RETROGRADE CARDIOPLEGIA [J].
HAYASHIDA, N ;
WEISEL, RD ;
SHIRAI, T ;
IKONOMIDIS, JS ;
IVANOV, J ;
CARSON, SM ;
MOHABEER, MK ;
TUMIATI, LC ;
MICKLE, DAG .
ANNALS OF THORACIC SURGERY, 1995, 59 (03) :723-729
[8]
HEARSE D, 1981, PROTECTION ISCHEMIC, P312
[9]
MYOCARDIAL PROTECTION FOR CORONARY-BYPASS GRAFTING - THE TORONTO HOSPITAL PERSPECTIVE [J].
IKONOMIDIS, JS ;
RAO, V ;
WEISEL, RD ;
HAYASHIDA, N ;
SHIRAI, T .
ANNALS OF THORACIC SURGERY, 1995, 60 (03) :824-832
[10]
LICHTENSTEIN SV, 1991, J THORAC CARDIOV SUR, V101, P269